Gastrectomy after neoadjuvant chemotherapy in five cases of locally advanced gastric cancer with pancreatic head invasion

被引：0
|
作者：
Kano, Mikihiro [1 ]
Tokumoto, Noriaki [1 ]
Tanabe, Kazuaki [2 ]
Hihara, Jun [1 ]
Toyota, Kazuhiro [3 ]
Hotta, Ryuichi [4 ]
Saeki, Yoshihiro [5 ]
Tazawa, Hirofumi [6 ,7 ]
Fujikuni, Nobuaki [8 ]
Hiroshima Surg Study Grp Clin Oncol HiSCO
机构：
[1] Hiroshima City North Med Ctr Asa Citizens Hosp, Dept Digest Surg, 1-2-1 Kameyama Minami,Asakita Ku, Hiroshima 7310293, Japan
[2] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Perioperat & Crit Care Management, Hiroshima, Japan
[3] Hiroshima Mem Hosp, Dept Surg, Hiroshima, Japan
[4] Higashihiroshima Med Ctr, Natl Hosp Org, Dept Surg, Higashihiroshima, Japan
[5] Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan
[6] Natl Hosp Org Kure Med Ctr, Dept Surg, Kure, Japan
[7] Chugoku Canc Ctr, Kure, Japan
[8] Hiroshima Prefectural Hosp, Dept Digest Surg, Hiroshima, Japan
来源：
INTERNATIONAL CANCER CONFERENCE JOURNAL | 2025年
关键词：
Gastric cancer; Neoadjuvant chemotherapy; Pancreatic invasion; OPEN-LABEL; GASTROESOPHAGEAL JUNCTION; PANCREATICODUODENECTOMY; ADENOCARCINOMA; COMPLICATIONS; CAPECITABINE; OXALIPLATIN;
D O I：
10.1007/s13691-025-00750-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Locally advanced gastric cancer (LAGC) with pancreatic head invasion (T4b) carries a poor prognosis despite radical surgery. Herein, we report the effectiveness of neoadjuvant chemotherapy (NAC) in improving the resectability of advanced gastric cancer with pancreatic invasion. A total of 2191 cases of gastric cancer were retrospectively analyzed from 13 institutions within the Hiroshima Surgical Study Group of Clinical Oncology (Hisco) database from 2018 to 2020. Among them, 5 of the 24 patients with Stage cT4b gastric cancer underwent NAC for three-to-eight cycles. Following chemotherapy, three patients underwent total gastrectomy, two patients underwent distal gastrectomy, and no patient underwent pancreaticoduodenectomy (PD). All five patients achieved a chemotherapeutic response of Grade 1b or higher, and only one case showed residual pancreatic invasion on pathology. This study suggests that NAC for Stage T4b LAGC with pancreatic head invasion may have the potential to obviate the need for PD.
引用
收藏
页码：147 / 154
页数：8
相关论文
共 50 条
  • [21] Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy
    Hu, Qing
    Wang, Jian
    Xu, Wei-Guo
    Shao, Peng
    Li, Gang
    PRECISION MEDICAL SCIENCES, 2021, 10 (02): : 78 - 82
  • [22] Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results
    Li, Ziyu
    Shan, Fei
    Wang, Yinkui
    Li, Shuangxi
    Jia, Yongning
    Zhang, Lianhai
    Yin, Daoxin
    Ji, Jianfu
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (10): : 4265 - 4271
  • [23] Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer
    Nishibeppu, Keiji
    Komatsu, Shuhei
    Ichikawa, Daisuke
    Imamura, Taisuke
    Kosuga, Toshiyuki
    Okamoto, Kazuma
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Otsuji, Eigo
    BMC CANCER, 2018, 18
  • [24] Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy
    Addeo, Pietro
    Rosso, Edoardo
    Fuchshuber, Pascal
    Oussoultzoglou, Elie
    De Blasi, Vito
    Simone, Gael
    Belletier, Christine
    Dufour, Patrick
    Bachellier, Philippe
    ONCOLOGY, 2015, 89 (01) : 37 - 46
  • [25] Oncological outcomes of laparoscopic versus open gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: a retrospective multicenter study
    Khaled, Islam
    Priego, Pablo
    Soliman, Hany
    Faisal, Mohammed
    Ahmed, Ihab Saad
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [26] Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer
    Biffi, Roberto
    Fazio, Nicola
    Luca, Fabrizio
    Chiappa, Antonio
    Andreoni, Bruno
    Zampino, Maria Giulia
    Roth, Arnaud
    Schuller, Jan Christian
    Fiori, Giancarla
    Orsi, Franco
    Bonomo, Guido
    Crosta, Cristiano
    Huber, Olivier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (07) : 868 - 874
  • [27] Response to neoadjuvant chemotherapy in locally advanced gastric and gastroesophageal cancer: Phase II clinical trial
    Samiei, F.
    Safaei, A. Maddah
    Esmati, E.
    Alibakhshi, A.
    Ashtiani, Mirai
    Haddad, P.
    Nosrati, H.
    Khanjani, N.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2015, 13 (03): : 259 - 264
  • [28] Laparoscopic versus open gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: a comprehensive contrastive analysis with propensity score matching
    Chenggang Zhang
    Peng Zhang
    Jiaxian Yu
    Qi Jiang
    Qian Shen
    Gan Mao
    Abu Bakarr Kargbo
    Weizhen Liu
    Xiangyu Zeng
    Yuping Yin
    Kaixiong Tao
    World Journal of Surgical Oncology, 21
  • [29] Neoadjuvant Chemotherapy Versus Direct Surgery for Locally Advanced Gastric Cancer With Serosal Invasion (cT4NxM0): A Propensity Score-Matched Analysis
    Xu, Wei
    Wang, Lingquan
    Yan, Chao
    He, Changyu
    Lu, Sheng
    Ni, Zhentian
    Hua, Zichen
    Zhu, Zhenglun
    Sah, Birendra Kumar
    Yang, Zhongyin
    Zheng, Yanan
    Feng, Runhua
    Li, Chen
    Yao, Xuexin
    Chen, Mingmin
    Liu, Wentao
    Yan, Min
    Zhu, Zhenggang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Time to surgery does not affect oncologic outcomes in locally advanced gastric cancer after neoadjuvant chemotherapy: a meta-analysis
    Liu, Zining
    Zhang, Zhening
    Liu, Hua
    Chen, Junbing
    FUTURE ONCOLOGY, 2023, 19 (05) : 397 - 408
12345